Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis

被引:15
作者
Floege, Juergen [1 ,11 ]
Jayne, David R. W. [2 ]
Sanders, Jan-Stephan F. [3 ]
Tesar, Vladimir [4 ,5 ]
Balk, Ethan M. [6 ]
Gordon, Craig E. [7 ]
Adam, Gaelen [6 ]
Tonelli, Marcello A. [8 ]
Cheung, Michael [9 ]
Earley, Amy [9 ]
Rovin, Brad H. [10 ]
机构
[1] Rhein Westfal TH RWTH Aachen, Univ Hosp, Div Nephrol, Aachen, Germany
[2] Univ Cambridge, Sch Clin Med, Div Expt Med & Immunotherapeut, Cambridge, England
[3] Univ Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands
[4] Charles Univ Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic
[5] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic
[6] Brown Univ, Ctr Evidence Synth Hlth, Sch Publ Hlth, Providence, RI USA
[7] Tufts Med Ctr, Div Nephrol, Boston, MA USA
[8] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[9] KDIGO, Brussels, Belgium
[10] Ohio State Univ, Dept Internal Med, Coll Med, Columbus, OH USA
[11] RWTH Aachen Univ Hosp, Div Nephrol, Pauwelsstr 30, D-52074 Aachen, Germany
关键词
ANCA-associated vasculitis; glomerular diseases; glomerulone-; phritis; guideline; KDIGO; systematic review; GLUCOCORTICOIDS;
D O I
10.1016/j.kint.2023.10.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In 2021, the Kidney Disease: Improving Global Outcomes (KDIGO) Guideline for the Management of Glomerular Diseases was published. KDIGO is committed to providing the nephrology community with periodic updates, based on new developments for each disease. For patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), avacopan received regulatory approval in late 2021, leading to this KDIGO guideline update. In addition, the evidence supporting a lower-dose glucocorticoid induction regimen or even complete replacement of glucocorticoids has become stronger. Herein, an executive summary of the most important guideline changes from the AAV chapter is provided as a quick reference.
引用
收藏
页码:447 / 449
页数:3
相关论文
共 11 条
  • [1] Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
    Charles, Pierre
    Terrier, Benjamin
    Perrodeau, Elodie
    Cohen, Pascal
    Faguer, Stanislas
    Huart, Antoine
    Hamidou, Mohamed
    Agard, Christian
    Bonnotte, Bernard
    Samson, Maxime
    Karras, Alexandre
    Jourde-Chiche, Noemie
    Lifermann, Francois
    Gobert, Pierre
    Hanrotel-Saliou, Catherine
    Godmer, Pascal
    Martin-Silva, Nicolas
    Pugnet, Gregory
    Matignon, Marie
    Aumaitre, Olivier
    Viallard, Jean-Francois
    Maurier, Francois
    Meaux-Ruault, Nadine
    Riviere, Sophie
    Sibilia, Jean
    Puechal, Xavier
    Ravaud, Philippe
    Mouthon, Luc
    Guillevin, Loic
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (08) : 1144 - 1150
  • [2] Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
    Cortazar, Frank B.
    Niles, John L.
    Jayne, David R. W.
    Merkel, Peter A.
    Bruchfeld, Annette
    Yue, Huibin
    Schall, Thomas J.
    Bekker, Pirow
    [J]. KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 860 - 870
  • [3] European Medicines Agency, First-in-class medicine recommended for treatment of rare blood vessel inflammation
  • [4] Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis A Randomized Clinical Trial
    Furuta, Shunsuke
    Nakagomi, Daiki
    Kobayashi, Yoshihisa
    Hiraguri, Masaki
    Sugiyama, Takao
    Amano, Koichi
    Umibe, Takeshi
    Kono, Hajime
    Kurasawa, Kazuhiro
    Kita, Yasuhiko
    Matsumura, Ryutaro
    Kaneko, Yuko
    Ninagawa, Keita
    Hiromura, Keiju
    Kagami, Shin-ichiro
    Inaba, Yosuke
    Hanaoka, Hideki
    Ikeda, Kei
    Nakajima, Hiroshi
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21): : 2178 - 2187
  • [5] Avacopan for the Treatment of ANCA-Associated Vasculitis
    Jayne, David R. W.
    Merkel, Peter A.
    Schall, Thomas J.
    Bekker, Pirow
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07) : 599 - 609
  • [6] Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Merkel, Peter A.
    Niles, John
    Jimenez, Richard
    Spiera, Robert F.
    Rovin, Brad H.
    Bomback, Andrew
    Pagnoux, Christian
    Potarca, Antonia
    Schall, Thomas J.
    Bekker, Pirow
    [J]. ACR OPEN RHEUMATOLOGY, 2020, 2 (11) : 662 - 671
  • [7] KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES
    Rovin, Brad H.
    Adler, Sharon G.
    Barratt, Jonathan
    Bridoux, Frank
    Burdge, Kelly A.
    Chan, Tak Mao
    Cook, H. Terence
    Fervenza, Fernando C.
    Gibson, Keisha L.
    Glassock, Richard J.
    Jayne, David R. W.
    Jha, Vivekanand
    Liew, Adrian
    Liu, Zhi-Hong
    Mejia-Vilet, Juan M.
    Nester, Carla M.
    Radhakrishnan, Jai
    Rave, Elizabeth M.
    Reich, Heather N.
    Ronco, Pierre
    Sanders, Jan-Stephan F.
    Sethi, Sanjeev
    Suzuki, Yusuke
    Tang, Sydney C. W.
    Tesar, Vladimir
    Vivarelli, Marina
    Wetzels, Jack F. M.
    Lytvyn, Lyubov
    Craig, Jonathan C.
    Tunnicliffe, David J.
    Howell, Martin
    Tonelli, Marcello A.
    Cheung, Michael
    Earley, Amy
    Floege, Juergen
    [J]. KIDNEY INTERNATIONAL, 2021, 100 (04) : S1 - S276
  • [8] US Food and Drug Administration, FDA approves add-on drug for adults with rare form of blood vessel inflammation
  • [9] The effects of plasma exchange in patients with ANCA- associated vasculitis: an updated systematic review and meta-analysis
    Walsh, Michael
    Collister, David
    Zeng, Linan
    Merkel, Peter A.
    Pusey, Charles D.
    Guyatt, Gordon
    Peh, Chen Au
    Szpirt, Wladimir
    Ito-Hara, Toshiko
    Jayne, David R. W.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
  • [10] Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
    Walsh, Michael
    Merkel, Peter A.
    Peh, Chen-Au
    Szpirt, Wladimir M.
    Puechal, Xavier
    Fujimoto, Shouichi
    Hawley, Carmel M.
    Khalidi, Nader
    Flossmann, Oliver
    Wald, Ron
    Girard, Louis P.
    Levin, Adeera
    Gregorini, Gina
    Harper, Lorraine
    Clark, William F.
    Pagnoux, Christian
    Specks, Ulrich
    Smyth, Lucy
    Tesar, Vladimir
    Ito-Ihara, Toshiko
    de Zoysa, Janak Rashme
    Szczeklik, Wojciech
    Flores-Suarez, Luis Felipe
    Carette, Simon
    Guillevin, Loic
    Pusey, Charles D.
    Casian, Alina L.
    Brezina, Biljana
    Mazzetti, Andrea
    McAlear, Carol A.
    Broadhurst, Elizabeth
    Reidlinger, Donna
    Mehta, Samir
    Ives, Natalie
    Jayne, David R. W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (07) : 622 - 631